FINLEY JOHN DAVID (Chief Financial Officer) received a stock award from PALISADE BIO, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/22/2024ACC: 0001493152-24-021045
Officer· Chief Financial Officer
Since Apr 2021
+666.00
Net shares
Net buyer
$3.3K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
666.00 acquired
Non-Derivative Transactions1
Common Stock, par value $0.01
Direct
Shares
+666.00
Price / share
$4.97
Trade value
$3.31K
% of position
9.8%
5/20/2024
6.77K→7.44K
Total
Net shares
+666.00
Net value
$3.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 Direct | 5/20/2024 | A · Award | +666.00 | $4.97 | $3.31K | 9.8% | 6.77K | 7.44K |
| Total | +666.00 | $3.31K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, par value $0.01
IndirectShares owned51.00
Total
51.00 indirect51.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.01 | 51.00 | Indirect |
| Total | 51.00 | 51.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported